European Medicines Agency (EMA) | What's new Follow Orphan designation: nanatinostat,valganciclovir Treatment of peripheral T-cell lymphoma, 10/08/2022 Withdrawn https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-22-2673 ema.europa.eu
